Osborne Clarke advised UCL Technology Fund on the investment.Bloomsbury Genetic Therapies Limited (“Bloomsbury”), a clinical-stage biotechnology company developing potentially curative treatments for patients suffering from rare…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Giulia Di Palma
…
This content is for Standard 1 Year members only. LoginJoin Now